


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.59%
-3.62%
-2.58%
+8.85%
-1.56%
NVO
Novo Nordisk A/S
$60.33
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
NVO Price Performance
$50.88 (+18.57%)
$49.11 (+22.85%)
$55.23 (+9.23%)
$78.83 (-23.47%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
NVO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook
NVO has Low risk level
Risks Indicators

Investors losing confidence

Hit 52-week low

Average key support and resistance price levels
LLY
1023.80
-1.51%
PFE
25.86
-2.36%
LEXX
0.76
-1.79%
VKTX
30.41
-3.15%
SNY
45.77
-3.62%
NVO
Novo Nordisk A/S
60.33
-4.07%
LEXX
Lexaria Bioscience
0.76
-1.79%
BKNG
Booking Holdings Inc
5085.22
-1.32%
IONQ
IonQ Inc.
45.80
+0.68%
QLYS
Qualys
132.69
-0.23%
What is NVO current stock price?
What are NVO stock strengths?
What is NVO Risk Level?
What is NVO market cap and volume?
What is NVO current Stock IQ?
Should I buy NVO stock right now?
Is NVO a Strong Buy right now?
What does a 'Strong Buy' rating mean for NVO?
What does a 'Strong Sell' rating mean for NVO?
What factors influence NVO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.59%
-3.62%
-2.58%
+8.85%
-1.56%
NVO
Novo Nordisk A/S
Current Price
$60.33
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
Linked to NVO
LLY
1023.80
-1.51%
PFE
25.86
-2.36%
LEXX
0.76
-1.79%
VKTX
30.41
-3.15%
SNY
45.77
-3.62%
Recently Viewed
NVO
Novo Nordisk A/S
60.33
-4.07%
LEXX
Lexaria Bioscience
0.76
-1.79%
BKNG
Booking Holdings Inc
5085.22
-1.32%
IONQ
IonQ Inc.
45.80
+0.68%
QLYS
Qualys
132.69
-0.23%

NVO Price Performance
$50.88 (+18.57%)
$49.11 (+22.85%)
$55.23 (+9.23%)
$78.83 (-23.47%)
NVO Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
NVO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook
NVO has Low risk level
Risks Indicators

Investors losing confidence

Hit 52-week low

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 10, 2026
Initiate
Outperform
CICC
Dec 16, 2025
Upgrade
Buy
BERENBERG
Nov 29, 2025
Reiterate
Buy
Goldman Sachs
Nov 25, 2025
Initiate
Overweight
Nov 20, 2025
Reiterate
Buy
NVO Stock IQ
NVO Latest Analysis
Novo Nordisk: Investors May Be In For An Earnings Surprise.
Wed Jan 28, 2026
What the Options Market Tells Us About Novo Nordisk. Financial giants have made a conspicuous ish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:) revealed 22 unusual trades.Delving into the details we found 59% of traders were ish while 31% showed bearish tendencies. Out of all the trades we spotted 5 were puts with a value of $239425 and 17 were calls valued at $902353.After evaluating the trading volumes and Open Interest it'.s evident that the major market m
Wed Jan 28, 2026
2 Pharmaceutical Stocks Set to Rebound in 2026. Key PointsNovo Nordisk could see stronger financial results this year thanks to new launches and label expansions.
Tue Jan 27, 2026
1 Pharmaceutical Stock Set to Rebound in 2026. Key PointsNovo Nordisk stock lost 40% of its value in 2025.
Tue Jan 27, 2026
Prediction: This Healthcare Stock Could Soar by 40% in 2026. Key PointsNovo Nordisk had a rough stretch in 2025 that eventually led to it firing its CEO.
Mon Jan 26, 2026
How Will Ozempic and Wegovy Sales Aid NVOs Upcoming Q4 Results?. Novo Nordisks Q4 results hinge on Ozempic and Wegovy sales as demand growth slows amid guidance cuts due to intense rivalry and compounded drug headwinds.
Mon Jan 26, 2026
Novo Nordisk Wegovy pill uptake negatively impacts syringe makers.
Fri Jan 23, 2026
Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock?. Novo Nordisk stock rose Friday on a report its oral Wegovy pill clocked 18000 prescriptions in its second week on the market.The post Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock? appeared first on Investor'.s Business Daily.
Fri Jan 23, 2026
Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade. Novo Nordisk (NVO) closed the most recent trading day at $59.32 moving 2.24% from the previous trading session.
Wed Jan 21, 2026
How Is The Market Feeling About Novo Nordisk AS?. ) short interest as a percent of float has risen 12.94% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will ...
Wed Jan 21, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.